Amy Welsh: Yes. You made that much tough to add to. That was very well said. I’ll maybe add some more context to Al’s point, the reason why I believe in the spillover is we had a, recently another large account in the Q3, timeframe for non-retail. We did some measuring, and we saw that that help to grow in that area in one state alone, about 60%., right? So, I think non-retail continues to be the bridge that strategically we wanted it to be to improve, retail, confidence with Twirla and offices perhaps where they haven’t even been prescribing it. So, as we continue to add more accounts that we are seeing true spillover and, partners like the Nurx who have been doing a good job this year. We’re looking forward to partnering even better and maybe even having a bit of a broader reach, in ‘24.
Now that they’ve stabilized and we have some good systems in place moving forward. So, and that’s just the couple of things that you know about, we’re constantly looking at other ways to improve. So, really for me it’s about optimizing the partners that we have. We have just begun to do well with them. So, I know we can do better.
Oren Livnat: Okay. If I may, you mentioned now that you’re on the goal line for ACA, really confident there. That seems like a change in tone, I think, from past calls where, you thought Washington is Washington, and see what happens, but it’s not something you’re, basing your expectations on. And, is there a change of tone there or something is something improved on that front?
Alfred Altomari: Yes. I mean, there is. How do I dance around this without being too political? I mean, look, it’s hard to ignore the last couple days in the country. I think reproductive rights are on top of mind everywhere in this country. So, Washington, I believe we do direct lobbying, including myself, with the folks that actually make these decisions, are looking to put up a win for women in this country. And brought in the reproductive rights, what’s interesting in the state we live in, or working, I should say, New Jersey, just put a very ACA like mandate in place that, so we see the state stepping up. We — but also the there’s a lot of people leaning into this and telling DC this has got to happen, because one of the things that was really interesting and wanted to congressional reports has studied this is unfortunately, who gets hurt worse by denying women coverage of brands is disenfranchised women and women of color.
They get hit hardest in this country, and it’s time for that to stop. So, I think our are drum beat, and as this is a unifying principle between all the competitors, if you will, in this space, we’re all leaning into this. It’s just, but I’m proud to say the work we’ve all done, I think, is on the goal line. So, our net, I so, yes, I feel more bullish, but we made a commitment to you and the street that we would not use that as an excuse for not getting to the goal line. We’ll get to the goal line without it. And this is on the morning after, this just throws a little bit of gasoline on what we hope is a hot brand already.
Oren Livnat: Alright. Thank you so much.
Operator: Thank you. [Operator Instructions] One moment for our next question please, comes from the line of Naz Rahman with Maxim Group. Please proceed.
Naz Rahman: Hi, everyone. Congrats on the progress, and thanks for taking my questions. I have a few. To touch on a point you just made, since President Biden issued that executive order over the summer, I believe the TRI Department is responsible for issuing additional FAQs regarding contraceptive reimbursements. Do you have any updates on potentially the TRI Department’s progress or any potential timelines among when we may see additional FAQs and what they may look like?
